Aims & Scope
Advances in Vaccines is a peer-reviewed, open access vaccines journal published by Directive Publications, advancing scholarship across vaccinology, immunization science, and vaccine-preventable disease control. The journal serves vaccinologists, immunologists, infectious disease researchers, public health scientists, clinicians, and veterinary researchers seeking a rigorous, internationally discoverable venue for original work.
We welcome research on vaccine platforms and development (mRNA, viral vector, subunit, conjugate, and adjuvanted vaccines), vaccine immunology and correlates of protection, immunogenicity, safety and efficacy evaluation, and clinical and translational vaccine studies. The journal also covers vaccine-preventable disease epidemiology (including measles, cholera, tetanus, and COVID-19), immunization programs, vaccine hesitancy and awareness, global vaccine equity and distribution, therapeutic and anticancer vaccines, and One Health and veterinary vaccinology.
We publish original research, systematic and narrative reviews, case reports, methods, and editorials. Every submission undergoes double-blind peer review; accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence with authors retaining copyright, and each receives a permanent Crossref DOI. Content is discoverable through OpenAlex and Google Scholar and is available for harvesting via our OAI-PMH endpoint, with editorial practice following COPE principles.
Subject Coverage
Advances in Vaccines welcomes original research, reviews, and case reports across the following core areas:
Research Topics
Core subject areas published in Advances in Vaccines — explore related research across our journals.
Articles
Frequently Asked Questions
What topics does Advances in Vaccines cover?
Advances in Vaccines covers the full breadth of vaccinology: vaccine platforms and development (mRNA, viral vector, subunit, conjugate, and adjuvanted vaccines), vaccine immunology and correlates of protection, immunogenicity and safety/efficacy evaluation, vaccine-preventable disease epidemiology (measles, cholera, tetanus, COVID-19), immunization programs, global vaccine equity and distribution, vaccine hesitancy, therapeutic and anticancer vaccines, and One Health/veterinary vaccinology.
Who should publish in and read Advances in Vaccines?
The journal is intended for vaccinologists, immunologists, infectious disease and public health researchers, clinical and translational scientists, epidemiologists, immunization program managers, and veterinary vaccine researchers. Authors working on vaccine development, immune response, vaccine-preventable diseases, vaccine equity, or therapeutic vaccines will find a relevant, discoverable home for their work.
Is Advances in Vaccines open access, and who holds copyright?
Yes. Advances in Vaccines is fully open access. Every accepted article is published under a Creative Commons Attribution (CC-BY 4.0) licence and authors retain copyright, so research is free to read, share, and reuse with attribution immediately on publication.
How does peer review work at Advances in Vaccines?
All submissions undergo double-blind peer review, in which author and reviewer identities are kept confidential to support impartial assessment. The journal follows COPE ethical principles for editorial decision-making, conflicts of interest, and handling of corrections and concerns.
What article types does Advances in Vaccines accept?
The journal accepts original research articles, systematic and narrative review articles, case reports, methods and protocols, and editorials across vaccine science. Review articles on topics such as mRNA platforms, vaccine immunology, and vaccine equity are especially welcome as authoritative reference works.
Does Advances in Vaccines assign a DOI and is it indexed?
Every published article receives a permanent Crossref DOI and is discoverable via OpenAlex and Google Scholar, with metadata available through our OAI-PMH endpoint. As a new open access vaccines journal, Advances in Vaccines is also preparing applications for additional indexing services such as DOAJ; those are stated as goals rather than completed listings.
What are the article-processing charges, and are waivers available?
Advances in Vaccines applies an article-processing charge only on acceptance to sustain open access publishing. Discounts and full waivers are available, particularly for authors from low- and middle-income countries and for those facing genuine funding constraints; contact the editorial office for current charges and waiver eligibility.
How do I submit my vaccine research manuscript to Advances in Vaccines?
Authors can submit through the journal's submission page after reviewing the author guidelines for formatting, ethics, and reporting requirements. Manuscripts in vaccinology, immunization, vaccine immunology, vaccine-preventable diseases, vaccine equity, and therapeutic or veterinary vaccines are all welcome.